Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
33.3%
% of PJP's 30 holdings also in MEDX
33.3%
% of MEDX's 30 holdings also in PJP
Overlap by Weight
Sector Drift (PJP minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PJP |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 5.2% | 9.6% | 5.2% |
|
JOHNSON & JOHNSON | 5.1% | 5.1% | 5.1% |
|
AMGEN INC | 5.0% | 6.3% | 5.0% |
|
ELI LILLY & CO | 4.7% | 16.8% | 4.7% |
|
PFIZER INC | 4.9% | 4.0% | 4.0% |
Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to MEDX
|
GILEAD SCIENCES INC | 5.2% |
|
ABBOTT LABORATORIES | 5.0% |
|
TARSUS PHARMACEUTICALS, INC. | 3.5% |
|
BIOSANTE PHARMACEUTICALS INC | 3.5% |
 |
PERRIGO CO | 3.1% |
|
COLLEGIUM PHARMACEUTICAL, INC. | 2.9% |
|
INNOVIVA, INC. | 2.8% |
|
PACIRA PHARMACEUTICALS INC | 2.8% |
|
SUPERNUS PHARMACEUTICALS INC | 2.8% |
|
LIQUIDIA TECHNOLOGIES, INC. | 2.7% |
PJP Underweight Relative to MEDX
|
ELI LILLY & CO | -12.1% |
 |
NOVARTIS AG-ADR | -6.6% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.6% |
|
ALNYLAM PHARMACEUTICALS INC | -4.7% |
|
ALKERMES PLC | -4.7% |
|
ABBVIE INC | -4.4% |
|
BRISTOL-MYERS SQUIBB CO | -3.6% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.7% |
|
CRISPR THERAPEUTICS AG | -2.4% |
|
IONIS PHARMACEUTICALS, INC. | -2.4% |